Media coverage
16
Media coverage
Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Morningstar.com Country/Territory United States Date 4/11/21 URL https://www.morningstar.com/news/pr-newswire/20211104ne63649/karyopharm-announces-new-interim-phase-2-selinexor-data-in-myelofibrosis-selected-for-oral-presentation-at-the-american-society-of-hematology-2021-annual-meeting-and-exposition Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet BioSpace Country/Territory United States Date 4/11/21 URL https://www.biospace.com/article/releases/karyopharm-announces-new-interim-phase-2-selinexor-data-in-myelofibrosis-selected-for-oral-presentation-at-the-american-society-of-hematology-2021-annual-meeting-and-exposition/?s=107 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Finanzen.net Country/Territory Germany Date 4/11/21 URL https://www.finanzen.net/nachricht/aktien/karyopharm-announces-new-interim-phase-2-selinexor-data-in-myelofibrosis-selected-for-oral-presentation-at-the-american-society-of-hematology-2021-annual-meeting-and-exposition-10707385 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet ADVFN UK Country/Territory United Kingdom Date 4/11/21 URL https://uk.advfn.com/stock-market/NASDAQ/KPTI/share-news/Karyopharm-Announces-New-Interim-Phase-2-Selinexor/86465394 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Yahoo! Finance Country/Territory United States Date 4/11/21 URL https://finance.yahoo.com/news/karyopharm-announces-interim-phase-2-143000872.html Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet TickerTech.com Country/Territory United States Date 4/11/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202111202111041030PR_NEWS_USPR_____NE63649 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet ProfitQuotes.com Country/Territory United States Date 4/11/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202111202111041030PR_NEWS_USPR_____NE63649 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Stockwatch Country/Territory Canada Date 4/11/21 URL www.stockwatch.com/News/Item/U-prNE63649-U!KPTI-20211104/U/KPTI Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet ADVFN US Country/Territory United States Date 4/11/21 URL https://www.advfn.com/p.php?pid=nmona&article=86465394 Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Hawaii News Now Country/Territory United States Date 4/11/21 URL www.hawaiinewsnow.com/prnewswire/2021/11/03/karyopharm-reports-strong-third-quarter-2021-financial-results-provides-business-highlights/ Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Fox 19 Country/Territory United States Date 4/11/21 URL www.fox19.com/prnewswire/2021/11/03/karyopharm-reports-strong-third-quarter-2021-financial-results-provides-business-highlights/ Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet KCBD Country/Territory United States Date 4/11/21 URL www.kcbd.com/prnewswire/2021/11/03/karyopharm-reports-strong-third-quarter-2021-financial-results-provides-business-highlights/ Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet Wave 3 Country/Territory United States Date 4/11/21 URL www.wave3.com/prnewswire/2021/11/03/karyopharm-reports-strong-third-quarter-2021-financial-results-provides-business-highlights/ Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet WFMZ-TV Online Country/Territory United States Date 4/11/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/karyopharm-announces-new-interim-phase-2-selinexor-data-in-myelofibrosis-selected-for-oral-presentation-at/article_866cc8fe-5207-5bbc-a025-6ba7ad758bf3.html Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition Media name/outlet VB Profiles Country/Territory United States Date 4/11/21 URL https://www.vbprofiles.com/press_releases/6183ef16b9abe43f3e84598d Persons Sundar Jagannath Title Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at the American Society of Hematology 2021 Annual Meeting and Exposition; -- 33% of Patients Who Received at Least 24 Weeks of Selinexor Treatment Achi Media name/outlet PR Newswire Country/Territory United States Date 4/11/21 Persons Sundar Jagannath